(Q46921335)

26 December 2017

title

Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation (English)

1 reference

26 December 2017

0 references

0 references

1 reference

6

1 reference

26 December 2017

author name string

T Reischig

1

1 reference

26 December 2017

P Jindra

2

1 reference

26 December 2017

O Hes

3

1 reference

26 December 2017

M Svecová

4

1 reference

26 December 2017

J Klaboch

5

1 reference

26 December 2017

language of work or name

English

0 references

publication date

31 October 2007

1 reference

26 December 2017

American Journal of Transplantation

published in

1 reference

26 December 2017

volume

8

1 reference

26 December 2017

issue

1

1 reference

26 December 2017

page(s)

69-77

1 reference

26 December 2017

Cytomegalovirus in transplantation - challenging the status quo.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02031.X

The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02031.X

The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02031.X

Role of cytomegalovirus infection in allograft rejection: a review of possible mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02031.X

Rat cytomegalovirus-accelerated transplant vascular sclerosis is reduced with mutation of the chemokine-receptor R33.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02031.X

Human cytomegalovirus subverts the functions of monocytes, impairing chemokine-mediated migration and leukocyte recruitment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02031.X

Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02031.X

Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02031.X

Antiviral drugs for cytomegalovirus in transplant recipients: advantages of preemptive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02031.X

Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02031.X

Measurement of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02031.X

Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02031.X

Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02031.X

Preemptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02031.X

Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02031.X

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02031.X

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02031.X

Valacyclovir for cytomegalovirus prophylaxis reduces the risk of acute renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02031.X

A comparative randomised study of valacyclovir vs. oral ganciclovir for cytomegalovirus prophylaxis in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02031.X

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02031.X

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02031.X

Protocol core needle biopsy and histologic Chronic Allograft Damage Index (CADI) as surrogate end point for long-term graft survival in multicenter studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02031.X

Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02031.X

Risk factors for cytomegalovirus viremia and disease developing after prophylaxis in high-risk solid-organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02031.X

Prospective comparison of valacyclovir and oral ganciclovir for prevention of cytomegalovirus disease in high-risk renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02031.X

Evaluation of pharmacokinetic interactions after oral administration of mycophenolate mofetil and valaciclovir or aciclovir to healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.02031.X

10.1111/J.1600-6143.2007.02031.X

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017